This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The companies will use IQVIA's Orchestrated Customer Engagement Platform to create Salesforce's LifeSciences Cloud for healthcare professional customer engagement.
The clinical trial results will be used to expand Viome’s mRNA platform, which in May received FDA breakthrough device designation for identifying early signs of oral and throat cancers.
The Washington-based company will combine Naring Health, DiscernDx and Foodome's resources with its offerings to develop more personalized nutrition options.
We’re excited to announce the launch of the LifeSciences Today Podcast by Healthcare IT Today. We’ve been thinking about getitng into the world of LifeSciences for a long time. Plus, LifeSciences needs and wants the real world data that provider organizations have in their systems.
Atropos Health , renowned for its evidence-based medicine, is expanding its award-winning Evidence Platform to redefine lifesciences applications. The company has added Dr. Sean Khozin, MD, MPH and Gerry McDougall to its LifeSciences Advisory Board, strengthening its growth in the field.
The lab, which works with AstraZeneca, Merck, Pfizer, Israel Biotech Fund and Teva Pharmaceuticals, as well as tech company Amazon Web Services, is currently accepting new applicants for its new challenge.
Together, the organizations will seek to harness the power of generative AI to help pharmaceutical and lifescience manufacturers drive efficiencies and business value while improving patient outcomes. Companies that find the optimal balance of human and AI-powered services will leap ahead in every industry, and pharma is no different.
INITIATE invests in and co-founds transformative companies at the intersection of healthcare, lifesciences, and technology. INITIATEs team deeply understands the challenges and opportunities that health tech and lifesciences companies face. The firm invests in startups poised to make a lasting impact.
Companies will have access to real-world patient data for clinical decision-making and research support, including hypothesis testing and cohort analysis.
Technical debt (tech debt), referring to the deferred maintenance and upgrades of a system, is commonly accrued in the healthcare and lifesciences industries. Get Ahead of the Problem Addressing tech debt, especially when its related to clinical and life-supporting technologies, can be a daunting task.
In the fast-paced world of lifesciences, embracing innovation has become a top priority for companies striving to stay ahead of the curve. With digital transformation, innovation is no longer a “nice to have” but the driving force behind lifesciences organizations’ success.
Mark Treshock, blockchain solutions leader for healthcare and lifesciences at IBM discusses how the technology can be used to validate vaccine supply chain and personal records.
When combined with Med-PaLM 2, providers and lifesciences companies can obtain answers to questions about patient medical records and general medical knowledge.
Humbi AIs Actuarial Intelligence will be an integral component of Innovaccers Healthcare Intelligence Cloud , unlocking new opportunities for providers, payers, and lifesciences organizations. For more information, visit innovaccer.com.
In addition, MDisrupt will add new features to the marketplace platform through a strategic collaboration with the Association to meet the needs of its members, providing new ways for them to engage with the health technology, health services, medical device, and lifesciences sectors.
Investment firm Kuwait LifeSciences Company's Dr. Mussaad M. Al-Razouki gives a breakdown of recently filed or finalized digital health SPACs, as well as a list of unicorns ripe for a potential merger.
Antidote will use SEQSTER's operating system to improve clinical trial time lines and enhance patient engagement for pharma and lifesciences companies.
We’re excited to be back for another episode of the LifeSciences Today Podcast by Healthcare IT Today. Check out the main topics of discussion for this episode of the LifeSciences Today podcast: Tell us about yourself and how you got into this adventure? I had the privilege of hosting Orr Inbar from Quanthealth.
At HIMSS23, Steven Lazer, global healthcare and lifesciences chief technology officer at Dell Technologies, joined MobiHealthNews to discuss Dell's work within digital health.
At-home diagnostics startup Viome LifeSciences has launched a new test to help detect oral and throat cancers. | The test relies on Viome’s proprietary RNA sequencing technology and AI to measure gene expression of the oral microbiome and human cells in each patient’s saliva, which are used to identify early biomarkers associated with oral and throat (..)
Alphabet's lifescience arm also announces the company's founder Andy Conrad will step down as CEO. Current president Stephen Gillett will take on the role in January.
HIMSS23: Epic analytics leader details efforts to bring GPT-4 into healthcare and growing work in genomics, lifesciences hlandi Thu, 04/20/2023 - 08:09
Diabetes management company Hygieia extended its Series B round, and Autonomize AI, a workflow platform for healthcare and lifesciences, also announced funding.
Reenita Das, partner and SVP for healthcare and lifesciences at Frost and Sullivan, said that femtech companies only accounted for 1.8% of total digital health investments in 2020.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content